Personalised Medicine

Attend SMi’s 2010 Personalised Medicine conference to study the latest developments in the science and the latest business strategies and partnership models moving the industry nearer to a personalised future.

Chaired by Cecilia Schott, Director of Business Development, AstraZeneca and by Martin Wilkins, Professor of Clinical Pharmacology and Head of the Division of Experimental Medicine, Imperial College London, the conference will cover key topics such as:

• Successful partnerships in personalised medicine – Jason Coloma, Roche Molecular Diagnostics
• Partnering for companion test development: perspective of a global IVD company – Iain Miller, bioMérieux
• Current challenges in the regulatory framework – Lincoln Tsang, Arnold & Porter LLP
• Deep resequencing as a tool for drug repositioning – John Whittaker, GlaxoSmithKline
• Integrating biomarker discovery and execution – Pearl Huang, Merck
• Safety and toxicity biomarkers – Gino Miele, Pfizer

Further Information: http://www.smi-online.co.uk/personalised19.asp